Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Novavax Inc (NQ: NVAX )

12.84 -0.09 (-0.73%)
Streaming Delayed Price Updated: 10:11 AM EDT, Sep 18, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Novavax Inc

< Previous 1 2
...
30 31 32 33 34 35 36 37 38
...
59 60 Next >
Shipment Delays Threaten the Best Advantage Novavax Has
The latest setback for NVAX stock is lower than expected delivery numbers for its Covid-19 vaccine. The longer it takes to get its vaccine into arms, the more it risks losing a critical advantage. 
Via InvestorPlace
52 Biggest Movers From Yesterday
Gainers BioDelivery Sciences International, Inc. (NASDAQ: BDSI) shares climbed 52.8% to close at $5.56 on Monday. Collegium Pharmaceutical will acquire BioDelivery Sciences... 
Via Benzinga
What Are Whales Doing With Novavax
A whale with a lot of money to spend has taken a noticeably bearish stance on Novavax. Looking at options history for Novavax (NASDAQ:NVAX) we detected 23 strange trades. 
Via Benzinga
Novavax Whale Trades Spotted
A whale with a lot of money to spend has taken a noticeably bearish stance on Novavax. Looking at options history for Novavax (NASDAQ:NVAX) we detected 11 strange trades. 
Via Benzinga
32 Stocks Moving In Monday's Mid-Day Session
Gainers BioDelivery Sciences International, Inc. (NASDAQ: BDSI) shares jumped 51.9% to $5.53. Collegium Pharmaceutical will acquire BioDelivery Sciences International at $5.60... 
Via Benzinga
The Week Ahead In Biotech (Feb. 13-19): Agios FDA Meeting, Avenue Adcom, Earnings And More
Biotech stocks moved back and forth amid some volatility before finishing the week ending Feb. 11 modestly lower, reversing the gains from the previous week. Earnings news flow continued to dominate... 
Via Talk Markets
The Week Ahead In Biotech (Feb. 13-19): Agios FDA Meeting, Avenue Adcom, Earnings And More
Biotech stocks moved back and forth amid some volatility before finishing the week ending Feb. 11 modestly lower, reversing the gains from the previous week. Earnings news... 
Via Benzinga
The Daily Biotech Pulse: Adcom Recommends Additional Trials For Lilly's Partnered Cancer Drug, Novavax Touts Pediatric Vaccine Data, TC Biopharm IPO
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Adcom Rules That Lilly May Have To Conduct Additional Studies For Co-... 
Via Benzinga
Novavax's COVID-19 Vaccine Shows 80% Effectiveness In Adolescent Study
Novavax Inc (NASDAQ: NVAX) said that its two-dose COVID-19 vaccine was 80% overall effective against COVID-19 in a late-stage trial testing the shot in teens aged... 
Via Benzinga
Novavax Stock Is a Buy After This Overdone Sell-Off
NVAX stock dropped too sharply on a negative Reuters article about Novavax, creating a great buying opportunity for investors. 
Via InvestorPlace
The Resumption Of Negotiations Between The U.S. And Iran May Lead To Lower Oil Prices
The US stock indices closed on the plus side on Tuesday. 
Via Talk Markets
Take a Leap Into Novavax Stock After Vaccine Sales Start
Novavax is worth speculating on at current levels. NVAX stock has fallen below the $100 mark ahead of its global Covid-19 vaccine launch. 
Via InvestorPlace
51 Biggest Movers From Yesterday
Also check out this: Apple And 3 Other Stocks Sold By Insiders Losers SelectQuote, Inc. (NYSE: SLQT) shares tumbled 47.3% to close at $3.44 on Tuesday after the company... 
Via Benzinga
Rumble SPAC News: 14 Things to Know About the Joe Rogan Offer Giving CFVI Stock a Rise
CF Acquisition (CFVI) stock is getting a boost Tuesday on news of SPAC merger target Rumble making an offer to Joe Rogan. 
Via InvestorPlace
DCFC Stock Alert: The News Giving EV Charging Play Tritium a Huge Jolt Today
Tritium (DCFC) stock charging higher on Tuesday after the company revealed the location of its next U.S. manufacturing factory. 
Via InvestorPlace
NVAX Stock Alert: Why Is Novavax Plunging Today?
Novavax hasn't delivered on an important 2021 promise. The future of NVAX stock looks grim as the vaccine race winds to a tentative close. 
Via InvestorPlace
Why Is Novavax Stock Dipping Tuesday?
Novavax Inc. (NASDAQ: NVAX) shares are trading lower Tuesday after the company acknowledged to Reuters that it has completed delivery of only about 10 million doses of its COVID 
Via Benzinga
Novavax Tumbles On Reports Of Underdelivering COVID-19 Vaccine Commitments
Novavax, Inc. (NASDAQ: NVAX) shares are tumbling Tuesday on a negative headline concerning the Maryland-based biopharma's COVID-19 vaccine. 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers BioCardia (NASDAQ:BCDA) stock inc... 
Via Benzinga
35 Stocks Moving In Tuesday's Mid-Day Session
Gainers Society Pass Incorporated (NASDAQ: SOPA) gained 63.4% to $3.45 after dropping 16% on Monday. American Rebel Holdings, Inc. (NASDAQ: AREB) climbed 56.1% to $3.45 following... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers Second Sight Medical (NASDAQ:EYES) stock increased by 7.8% to $1.51 during Tuesday's pre-market session. The market value of their outstanding shares is at $59... 
Via Benzinga
NVAX Stock Alert: The Covid-19 Vaccine News Sending Novavax Higher Today
News that Australia has received its first shipment of Novavax's Covid-19 vaccine has NVAX stock taking off nearly 9% in today's trading. 
Via InvestorPlace
Germany's Vaccine Commission Recommends Novavax's COVID-19 Vaccine For Adults: Reuters
Germany's expert panel on vaccine use has recommended Novavax Inc's (NASDAQ: 
Via Benzinga
Novavax Can Still Succeed, But It’s Facing High Risks
Novavax's vaccine revenues haven't soared yet. But if the FDA approves the shot, the odds could change for NVAX stock. 
Via InvestorPlace
Avoid Novavax for Now, Until the Picture Clears Up
NVAX stock may have seen a near-term bounce following the completion of filing of EUA filing with the FDA, but it may not be a buy yet. 
Via InvestorPlace
This Is What Whales Are Betting On Novavax
A whale with a lot of money to spend has taken a noticeably bearish stance on Novavax. Looking at options history for Novavax (NASDAQ:NVAX) we detected 14 strange trades. 
Via Benzinga
Novavax Should Move Higher After International Distribution Efforts
In the wake of a multitude of positive press releases, NVAX stock traders should prepare for an imminent bounce in the share price. 
Via InvestorPlace
World Markets News for Tuesday
Exxon is splitting into 3 with its new restructuring move: upstream; chemicals; and low-carbon. 
Via Talk Markets
7 Great Cheap Stocks to Buy for Solid Growth in 2022
These cheap stocks have a robust growth visibility for the coming years, making them worth considering in the current market correction. 
Via InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
< Previous 1 2
...
30 31 32 33 34 35 36 37 38
...
59 60 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.